Improvement of Splenomegaly and Pancytopenia by Enzyme Replacement Therapy Against Type 1 Gaucher Disease: A Report of Sibling Cases
- 56 Downloads
Gaucher disease is a genetic lipid storage disease and represents a potentially serious health problem. It arises from a deficiency of glucocerebrosidase activity with secondary accumulation of large quantities of glucocerebroside. Symptoms are usually multisystemic, often debilitating or disabling, and sometimes disfiguring, and they can lead to death. We report objective clinical responses to repeated infusion of human placental and recombinant glucocerebrosidase in 2 patients with type 1 Gaucher disease and increased hemoglobin levels and platelet counts. Splenic volume decreased during the period of enzyme administration. Enzyme replacement therapy has improved the treatment of type 1 Gaucher disease by safely and effectively arresting, decreasing, or normalizing many of its major signs and symptoms. Consideration by physicians must be given to Gaucher disease, and appropriate treatments must be given when confronted with cryptogenic pancytopenia or hepatosplenomegaly.
Key wordsType 1 Gaucher disease Enzyme replacement therapy Alglucerase Imiglucerase
Unable to display preview. Download preview PDF.
- 1.Barton NW, Rosenthal DI, Mankin HJ, et al. Skeletal responses to enzyme replacement therapy in patients with Gaucher disease: what are the goals and expectations of treatment?Gaucher Clin Perspect. 1996;4:2–7.Google Scholar
- 2.Pastores GM, Einhorn TA. Skeletal complications of Gaucher disease: pathophysiology, evaluation, and treatment.Semin Hematol. 1995;32(suppl 1):20–27.Google Scholar
- 3.Baronage JA, Rice E. An overview of Gaucher disease.Gaucher Clin Perspect. 1993;1:1–5.Google Scholar
- 20.Friedman B, Vaddi K, Preston C, Mahon E, Caltado JR, McPherson JM. A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived betaglucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease.Blood. 1999;93:2807–2816.PubMedGoogle Scholar
- 23.Grabowski GA. Gaucher disease: enzymology, genetics, and treatment. In Harris H, Hirschhorn K, eds.Advances in Human Genetics. New York: Plenum Press; 1993:377–441.Google Scholar